feed,title,long_url,short_url
MedRxiv,"COVID-19 Vaccine Concerns about Safety, Effectiveness and Policies in the United States, Canada, Sweden, and Italy among Unvaccinated Individuals",https://medrxiv.org/cgi/content/short/2021.09.09.21263328v1?rss=1,https://j.mp/2VvaAWw
MedRxiv,Epidemic Models for COVID-19 during the First Wave from February to May 2020: a Methodological Review,https://medrxiv.org/cgi/content/short/2021.09.02.21263033v1?rss=1,https://j.mp/3jZcrMI
MedRxiv,"Exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with Delta variant in England during May to July 2021",https://medrxiv.org/cgi/content/short/2021.09.02.21262979v1?rss=1,https://j.mp/3tystAA
MedRxiv,metaCOVID: An R-Shiny application for living meta-analyses of COVID-19 trials,https://medrxiv.org/cgi/content/short/2021.09.07.21263207v1?rss=1,https://j.mp/3yZ8b3Z
MedRxiv,Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort,https://medrxiv.org/cgi/content/short/2021.09.03.21263023v1?rss=1,https://j.mp/38WVj3T
MedRxiv,Induction of trained immunity by influenza vaccination - impact on COVID-19,https://medrxiv.org/cgi/content/short/2021.09.03.21263028v1?rss=1,https://j.mp/2Vxj3sh
MedRxiv,Seroprevalence of anti-SARS-CoV-2 IgG and IgA antibodies before the launch of COVID-19 vaccination in Kazakhstan,https://medrxiv.org/cgi/content/short/2021.09.03.21262885v1?rss=1,https://j.mp/3A1UiDL
MedRxiv,Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform,https://medrxiv.org/cgi/content/short/2021.09.03.21262888v1?rss=1,https://j.mp/3BVjR9U
